Your browser doesn't support javascript.
loading
Canakinumab Versus Placebo in Combination With First-Line Pembrolizumab Plus Chemotherapy for Advanced Non-Small-Cell Lung Cancer: Results From the CANOPY-1 Trial.
Tan, Daniel S W; Felip, Enriqueta; de Castro, Gilberto; Solomon, Benjamin J; Greystoke, Alastair; Cho, Byoung Chul; Cobo, Manuel; Kim, Tae Min; Ganguly, Sandip; Carcereny, Enric; Paz-Ares, Luis; Bennouna, Jaafar; Garassino, Marina Chiara; Schenker, Michael; Kim, Sang-We; Brase, Jan C; Bury-Maynard, Denise; Passos, Vanessa Q; Deudon, Stéphanie; Dharan, Bharani; Song, Yuanbo; Caparica, Rafael; Johnson, Bruce E.
Afiliação
  • Tan DSW; National Cancer Centre Singapore, Duke-NUS Medical School, Singapore, Singapore.
  • Felip E; Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Barcelona, Spain.
  • de Castro G; Instituto do Câncer do Estado de São Paulo, São Paulo, Brazil.
  • Solomon BJ; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
  • Greystoke A; Northern Centre for Cancer Care, Newcastle upon Tyne NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.
  • Cho BC; Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Cobo M; Medical Oncology Intercenter Unit, Regional University Hospital and Virgen de la Victoria University Hospital, IBIMA, Málaga, Spain.
  • Kim TM; Seoul National University Hospital, Seoul, Republic of Korea.
  • Ganguly S; Tata Medical Center, Kolkata, India.
  • Carcereny E; Catalan Institute of Oncology, Badalona Applied Research Group in Oncology (B-ARGO), Barcelona, Spain.
  • Paz-Ares L; University Hospital 12 de Octubre, Madrid, Spain.
  • Bennouna J; Department of Medical Oncology, Centre Hospitalier Universitaire de Nantes, Nantes, France.
  • Garassino MC; Department of Medicine, Section Hematology Oncology, Thoracic Oncology program, The University of Chicago, Chicago, IL.
  • Schenker M; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Kim SW; Sf Nectarie Oncology Center Craiova and the University of Medicine and Pharmacy of Craiova, Craiova, Romania.
  • Brase JC; Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Bury-Maynard D; Novartis Pharma AG, Basel, Switzerland.
  • Passos VQ; Novartis Pharmaceuticals Corporation, Cambridge, MA.
  • Deudon S; Novartis Pharmaceuticals Corporation, East Hanover, NJ.
  • Dharan B; Novartis Pharma AG, Basel, Switzerland.
  • Song Y; Novartis Pharmaceuticals Corporation, East Hanover, NJ.
  • Caparica R; Novartis Pharmaceuticals Corporation, East Hanover, NJ.
  • Johnson BE; Novartis Pharma AG, Basel, Switzerland.
J Clin Oncol ; 42(2): 192-204, 2024 Jan 10.
Article em En | MEDLINE | ID: mdl-38039427
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Limite: Humans Idioma: En Revista: J Clin Oncol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Singapura
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Limite: Humans Idioma: En Revista: J Clin Oncol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Singapura